
Analyst Price Targets: When +569% Upside Is Just Arithmetic
Two providers published consensus targets of $35.75 and $10.50 for the same company on the same day. What that means…
Track newly launched stocks, analyst recommendations, price movements and key dates for the latest initial public offerings.

Two providers published consensus targets of $35.75 and $10.50 for the same company on the same day. What that means…

Rivian's Q3 2026 gross profit was $176 million — but its automotive segment lost $80 million. The difference came from…

IPO winners and losers in 2026: of 320 tracked listings, 104 rose 25%+ and 76 fell 25%+. Which gains were…

Discord turned down $12bn from Microsoft in 2021. The funds that must file a price now mark it between $26.51…

Venture Global posted a record $2.5bn quarter and raised guidance, but a May 2027 hearing seeks over $6bn and the…

SpaceX unlocks $46.7bn on 8 December — 2.6% of the company and under three days of its own volume. Fifteen…

Chinese media and research houses estimate 2025 revenue of about RMB 42 billion (roughly $5.8 billion), up around 40%, of…

Five years ago, Anthropic was a small research lab with no product. In the third quarter of 2026 it booked…

The Amazon-backed reactor developer priced at $23 — well above its $16–19 range — raised $1.02 billion in the largest…

The board is chaired by Chris Viehbacher, the former CEO of Sanofi and most recently CEO of Biogen (2022–2024) —…

The global atopic dermatitis market reached $21.15 billion in 2026 and is projected to grow at 9.5% CAGR to $33.3…

$150M IPO + $257M pre-IPO capital. Strong cash position. The cash runway is sufficient to fund Phase 2 initiation and…

Vogenx has the right drug for the right disease at the right moment. The $81M raised provides runway to the…

The 1.1 billion metric tonne inferred resource at 1,233 ppm TREO is a large-scale figure that requires contextualisation. This is…

The global pain management market was valued at approximately $80–90 billion in 2025 and is projected to reach $120–140 billion…

Every electric vehicle on the road today — whether it carries a Tesla badge, a VW logo, or a BYD…

PureCycle Technologies holds an exclusive worldwide licence from Procter & Gamble for a patented purification technology that does what no…

23% revenue growth to $65.8 million, 81% EPS growth to $0.225, zero debt, a P/E ratio of 8.3× at a…

The brand is genuine: Suja Organic has 30,000+ retail distribution points, strong brand recognition in the natural foods channel, and…

These five, in our view, have fallen for reasons that look more like valuation resets or technical/liquidity effects than deteriorating…

The global sleep apnea device and drug market is estimated at $9–11 billion annually, with pharma analysts projecting a successfully-approved…

The AstraZeneca partnership, announced before the IPO, is the company's most significant external validation. AZ committed up to $420 million…

The most credible near-term data point in the STDN story is its disclosed contract backlog: $245 million total, of which…

Since peaking at $225.64 on June 16, 2026 — five days after the largest IPO in history — SpaceX (NASDAQ:…

Bending Spoons raised $1.68 billion on July 1, 2026, making it the largest Italian tech IPO in history and one…

Revenue jumped 198% year-over-year to approximately $34.5 billion for a single quarter. The gross margin was 79.3%. The operating margin…

Sinda Ltd. raised $213 million from its IPO plus $110 million from Fresnillo, the world's top primary silver producer, in…

Revenue is growing at 50%, and after a 45% pullback the gap between Karman's fundamental trajectory and its stock price…

A $650 million IPO, a $1.1 billion contract backlog, and customers including SpaceX, Boeing, Lockheed Martin, and NASA — and…

The $930 million order backlog as of March 31, 2026 is direct evidence of this embedded position. It is not…

The most credible near-term customers are hyperscale data center operators. The AI infrastructure buildout has created a power demand crisis…

A company can be worth billions of dollars without selling a single commercial product, while one successful clinical trial can…

The Sunshine Mine could produce approximately 6.7–7.6 million ounces of silver annually during its first five years of operation. That…

After artificial intelligence became the dominant investment theme of the decade, many technology investors have started looking for the next…

One of the most interesting aspects of the SpaceX story is that several publicly traded companies already hold stakes or…

At an IPO price of $135 per share and an implied valuation approaching $1.75 trillion, SpaceX is preparing for what…

Elmet is not simply a metal fabrication company. It sits at the intersection of several of the most strategically important…

Conexeu is attempting to develop biomaterial solutions that can help the body regenerate tissue more effectively. Aging populations, rising cosmetic…

Almost every major publicly traded electric aviation company is deeply negative since IPO or SPAC launch. Investor enthusiasm has cooled…

AMSS has lost roughly 50% of its value despite operating in one of the fastest-growing segments of the beverage industry:…

The company entered public markets with the largest IPO of the year, raising over $5.5 billion at an offering price…

While many competitors are still focused on concepts, simulations, and future promises, BETA is already flying aircraft, building charging infrastructure,…

Fervo Energy may be one of the most important IPOs of 2026 because it sits exactly where Wall Street currently…

Between September 2025 and May 2026, about 235 IPOs entered the US market. Thirty-eight of these – roughly one in…

Hemab Therapeutics (COAG) targets rare inherited bleeding disorders with what could be a first-in-class preventive therapy — and zero commercial…

According to company materials, over 60% of Nasdaq-100 companies are customers, and data centers have become its fastest-growing vertical.

VG already generates billions in revenue, billions in profit, and operates in one of the most strategically important industries in…

The cartilage repair represents a very large global orthopedic opportunity with substantial unmet medical need. Existing treatment approaches such as…

Rare Earths Americas is not simply another mining company preparing for listing. It is positioning itself as part of a…

In a market crowded with speculative biotech names, Avalyn Pharma Inc. stands out for targeting a specific and high-value niche:…

The company generated nearly $760 million in annual revenue, remains profitable, and technical indicators still point toward a bullish setup.…

Most recent IPOs have followed a familiar pattern: exciting narrative, weak fundamentals, and explosive volatility. Cardinal Infrastructure Group Inc. (CDNL)…

Zero revenue. $70 million in annual losses. Yet a market valuation of nearly $2.7 billion and a stock that has…

Swarmer Inc. shares jumped hundreds of percent—at times nearly 1,000 percent—in a matter of days, becoming one of the most…

A company generating just a few million dollars in revenue, yet valued in the hundreds of millions? Behind Agencia Comercial…